ConcertAI’s TeraRecon Eureka clinical AI platform provides physicians with cutting-edge artificial intelligence and deep learning technologies to deliver next-generation CT and MR imaging through Cercare Perfusion, a fully automated, easy-to-use patient-specific perfusion software.
Brain perfusion scans measure blood flow in the brain and are used to provide much-needed information about the extent of tissue damage, for example due to an acute ischemic stroke.1 Rapid mapping of brain perfusion deficits is crucial to minimize tissue damage when treating an acute stroke. and Cercare further enriches the workflow with AI layers to create volumetric measurements that directly impact clinical decision making.2
“We are excited to be joining forces with another disruptive technology company like Cercare,” said Dan McSweeney, President of TeraRecon. “This partnership demonstrates our continued commitment to partnering with leading, like-minded, innovative companies to provide rapid access to critical patient data and ultimately improve clinical impact.”
“TeraRecon and Cercare Medical share a shared commitment to support clinical decision making to enable the best possible patient care,” said Kim Beuschau Mouridsen, CEO of Cercare Medical. “We are excited to enter into this global partnership to increase access to the latest perfusion technology, designed to easily integrate into existing workflows and provide healthcare professionals with deep, rapid and reliable patient insights.”
Cercare offers unique maps that illustrate oxygen availability as well as blood flow and volume. This allows for a more detailed assessment of tissue pathology and therefore optimized patient management for a variety of use cases including oncology, Alzheimer’s and neoplasia.
Eureka Clinical AI is the leading AI SaaS image interpretation and clinical decision augmentation solution from ConcertAI’s TeraRecon. As the industry’s most widely used platform, it is unique in that it is open to third-party AI algorithms and allows for consolidated management of all AI interpretation solutions with seamless PACS integration. Multi-specialty care teams can see outcomes and receive mobile notifications to confirm AI findings, ensuring optimal and timely patient interventions, management, and coordinated care delivery.
